Pages that link to "Q36823493"
Jump to navigation
Jump to search
The following pages link to The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society (Q36823493):
Displaying 50 items.
- Treatment of bladder cancer in the elderly (Q26744163) (← links)
- Primary clear cell adenocarcinoma of the bladder with recurrence: a case report and literature review (Q26858864) (← links)
- Targeting Hsp90 in urothelial carcinoma (Q27023406) (← links)
- A Review of Outcomes for Stage Ta Bladder Tumors (Q30248717) (← links)
- Factors Influencing Aggressive Therapy for Bladder Cancer: An Analysis of Data From the SEER Program (Q30881767) (← links)
- Prevalence and prognostic significance of microsatellite alterations in young patients with bladder cancer. (Q31161907) (← links)
- The impact of real-time 3d imaging by ultra-high speed optical coherence tomography in urothelial carcinoma (Q34449687) (← links)
- Internet health resources and the cancer patient (Q34747660) (← links)
- Sex Disparities in Cancer Mortality and Survival (Q35156810) (← links)
- Gender, racial and age differences in bladder cancer incidence and mortality. (Q35744804) (← links)
- Bladder cancer: worse survival in women from deprived areas (Q35776927) (← links)
- Is there a gender effect in bladder cancer? A population-based study of practice and outcomes (Q35956254) (← links)
- Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysis (Q36117964) (← links)
- Profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases proteins in bladder urothelial carcinoma (Q36216777) (← links)
- Bladder cancer update. Current evaluation methods and standard of care (Q36665122) (← links)
- Nonurothelial cancer of the bladder (Q36729158) (← links)
- Urothelial carcinoma management in elderly or unfit patients (Q37030514) (← links)
- Experimental rat bladder urothelial cell carcinoma models (Q37222356) (← links)
- Emerging intravesical therapies for management of nonmuscle invasive bladder cancer (Q37283563) (← links)
- Predicting response to bacillus Calmette-Guérin (BCG) in patients with carcinoma in situ of the bladder (Q37635650) (← links)
- Nanostructured bladder tissue replacements (Q37781773) (← links)
- Bladder cancer: a review of non-muscle invasive disease (Q37791398) (← links)
- Disparities in bladder cancer (Q37962703) (← links)
- Does patient age affect survival after radical cystectomy? (Q38007021) (← links)
- Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder cancer patients (Q38473174) (← links)
- Challenges with in vitro and in vivo experimental models of urinary bladder cancer for novel drug discovery. (Q38808040) (← links)
- Infiltration related miRNAs in bladder urothelial carcinoma (Q39298822) (← links)
- Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer (Q40715310) (← links)
- Gender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National Registry of Urinary Bladder Cancer (Q40839403) (← links)
- Intravesical chemotherapy and immunotherapy for superficial tumors Basic mechanism of action and future direction (Q40853260) (← links)
- FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes (Q41471202) (← links)
- The expression of vasohibin-1 and its prognostic significance in bladder cancer (Q42376451) (← links)
- Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease. (Q44132072) (← links)
- Presentation and outcome following radical cystectomy in Hispanics with bladder cancer (Q44470687) (← links)
- Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer. (Q44890175) (← links)
- Long-term follow-up of TaG1 non-muscle-invasive bladder cancer (Q44949769) (← links)
- Gender-specific survival following radical cystectomy for pT4 bladder cancer. (Q45362887) (← links)
- Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis (Q45363607) (← links)
- Office-based Bladder Tumor Fulguration and Surveillance: Indications and Techniques (Q45406953) (← links)
- XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIβ mRNA stability (Q47282727) (← links)
- Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma (Q47408867) (← links)
- Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013). (Q47552725) (← links)
- Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition (Q47800676) (← links)
- Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder (Q51292827) (← links)
- Patterns of hematuria referral to urologists: does a gender disparity exist? (Q51694266) (← links)
- Polymers with nano‐dimensional surface features enhance bladder smooth muscle cell adhesion (Q51796201) (← links)
- Current status of diagnosis and treatment of bladder cancer in China - Analyses of Chinese Bladder Cancer Consortium database. (Q53073693) (← links)
- Combined use of urinary Survivin detection and liquid-based cytology for the early diagnosis of bladder urothelial carcinoma. (Q55004870) (← links)
- Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening. (Q55314159) (← links)
- Gender differences in stage distribution of bladder cancer (Q57307308) (← links)